Riskpilot← Back to searchSign inGet full accessBiomedrex AB
ABActiveOrg 5590015532Liljestrands Väg 10Research and experimental development on natural sciences and engineering · NACE 7210Est. 20153 employees
Revenue 2025
SEK 0
EBITDA margin
—
+182% vs 2024
Equity ratio
34.3%
Financial strength
Net profit 2025
SEK -549K
-273% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK 1,2M | +182% |
| Net profit | SEK -549K | -273% |
| Total assets | SEK 18,8M | +10% |
| Equity | SEK 6,5M | +29% |
| Employees | 3 | — |
Legal name
Biomedrex AB
Org number
5590015532
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
26 januari 2015
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Pramer, Theodor Anastasius Wallgren, Karl-Fredrik Nils Gustaf
Company purpose
Bolaget skall verka inom medicinutveckling, medicinteknik och därmed förenlig verksamhet.
Address
Liljestrands Väg 10
Phone
+46704242420
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | −1 290 | −1 134 | −1 219 |
| EBITDA | −347 | −624 | 581 | 442 | 1 245 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −347 | −624 | 581 | 442 | 1 245 |
| Net financials | −45 | −206 | −197 | −124 | −1 795 |
| Profit before tax | −392 | −830 | 384 | 318 | −549 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −392 | −830 | 384 | 318 | −549 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 756 | 14 893 | 15 970 | 17 181 | 18 840 |
| Equity | 4 252 | 4 118 | 4 702 | 5 020 | 6 471 |
| Long-term debt | 1 509 | 7 618 | 7 501 | 8 299 | 8 063 |
| Short-term debt | 995 | 3 156 | 3 767 | 3 862 | 4 307 |
| Total debt | 2 504 | 10 774 | 11 268 | 12 161 | 12 369 |
EBITDA margin
124540900.0%
This company
15.8%
Market median
+788233444% vs market
20212025
Equity ratio
34.3%
This company
38.2%
Market median
+10% vs market
20212025
Return on equity
-8.5%
This company
18.4%
Market median
-146% vs market
20212025
Net profit margin
-54918400.0%
This company
8.1%
Market median
-678005038% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TA Chief Executive Officer | Chief Executive Officer | 2022 |
KN Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Former (1) | ||
ME Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Chairman | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Biomedrex AB 
Biomedrex invest ABBoard members of Biomedrex AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marjo-Riitta Emilia Puumalainen | Chief Executive Officer | 0 companies |
| Theodor Anastasius Pramer | Chief Executive Officer | 0 companies |
| Karl-Fredrik Nils Gustaf Wallgren | Deputy Chief Executive Officer | 0 companies |
| Lena Maria Pramer | Deputy Board Member | 0 companies |
| Bo Martin Mikael Ekenberg | Chairman | 0 companies |